These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15271007)

  • 21. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of implantable cardiac defibrillators for primary prophylaxis in the community: baseline risk and clinically meaningful benefits.
    Jolly S; Dorian P; Alter DA
    J Eval Clin Pract; 2006 Apr; 12(2):190-5. PubMed ID: 16579828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Regarding the French Society of Cardiologists' guidelines on the indications for implantable automatic ventricular defibrillators].
    Daubert JC
    Arch Mal Coeur Vaiss; 2006 Feb; 99(2):93-4. PubMed ID: 16555690
    [No Abstract]   [Full Text] [Related]  

  • 24. Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.
    Tung R; Swerdlow CD
    Circulation; 2009 Sep; 120(10):825-7. PubMed ID: 19704090
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter by Boriani et al regarding article, "Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study".
    Boriani G; Diemberger I; Grigioni F
    Circulation; 2008 Sep; 118(14):e515; author reply e516. PubMed ID: 18824650
    [No Abstract]   [Full Text] [Related]  

  • 26. Unresolved issues in implantable cardioverter-defibrillator therapy.
    Mason PK; DiMarco JP
    Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
    Cotiga D; Ehlert F; Sherrid M
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implantable cardioverter-defibrillators save lives. Why are only 15-20 percent of those who might benefit offered these souped-up pacemakers?
    Health News; 2005 Aug; 11(8):5-6. PubMed ID: 16184639
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nursing care for automatic implantable defibrillators].
    Pépin A; Samuel B; Kihel A
    Soins; 2006; (702 Suppl):S3-5. PubMed ID: 16493932
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk assessment with cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Gosling OE; Bellenger N; Spurrell P
    Heart; 2009 Nov; 95(22):1843. PubMed ID: 19875370
    [No Abstract]   [Full Text] [Related]  

  • 33. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implanted cardioverter defibrillators for the prevention of sudden death.
    Dorian P; Talajic M; Tang A
    Can J Cardiol; 2005 May; 21 Suppl A():31A-36A. PubMed ID: 15953942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
    Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The implantable cardioverter-defibruillators used in the prophylaxis of sudden cardiac death].
    Kluizhev VM; Ardashev VN; Ardashev AV; Zheliakov EG
    Voen Med Zh; 2004 Sep; 325(9):26-30. PubMed ID: 15537098
    [No Abstract]   [Full Text] [Related]  

  • 38. Sudden death prevention with implantable devices.
    Passman R; Kadish A
    Circulation; 2007 Jul; 116(5):561-71. PubMed ID: 17664385
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anxiety and anxiety management in patients with implanted cardioverter-defibrillators].
    Ladwig KH; Wirsching C; V Hammerstein A; Danner R; Baumert J; Schmitt C
    Dtsch Med Wochenschr; 2004 Oct; 129(43):2311-5. PubMed ID: 15483771
    [No Abstract]   [Full Text] [Related]  

  • 40. Implantable cardioverter-defibrillator and mortality in dialysis patients.
    Saravanan P; Davidson NC
    Am J Cardiol; 2009 Jun; 103(11):1623-4. PubMed ID: 19463528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.